SCHEMBL16930823

SCHEMBL16930823

CC(C)COC(=O)c1ccc(C(N)=NC=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PLA2G1B P04054 1/20 0.47
▸ ATG4B Q9Y4P1 1/20 0.47
▸ ALDH1A1 P00352 3/20 0.46
▸ TSHR P16473 2/20 0.46
▸ MAPT P10636 1/20 0.44
▸ SCN1A P35498 1/20 0.43
▸ SCN2A Q99250 1/20 0.43
▸ SCN3A Q9NY46 1/20 0.43
▸ ADRB2 P07550 5/20 0.43
▸ ADRB1 P08588 5/20 0.43
▸ ADRB3 P13945 5/20 0.43
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ SLC1A5 Q15758 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MAOA P21397 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL110051 0.82 ALDH1A1 (0.64) PLA2G1BATG4BALDH1A1TSHRMAPT
SCHEMBL16930807 0.80 ALDH1A1 (0.55) PLA2G1BATG4BALDH1A1TSHRMAPT
SCHEMBL27667934 0.80 ALDH1A1 (0.62) PLA2G1BATG4BALDH1A1TSHRMAPT
SCHEMBL27668352 0.80 ALDH1A1 (0.62) PLA2G1BATG4BALDH1A1TSHRMAPT
SCHEMBL27668055 0.80 ALDH1A1 (0.62) PLA2G1BATG4BALDH1A1TSHRMAPT
SCHEMBL16930816 0.79 MAPT (0.55) ALDH1A1TSHRMAPTNPC1RAB9A
SCHEMBL18966428 0.78 ADRB2 (0.61) PLA2G1BATG4BALDH1A1TSHRMAPT
SCHEMBL8169325 0.78 ALDH1A1 (0.51) PLA2G1BATG4BALDH1A1TSHRMAPT
Isobutamben SCHEMBL25178 0.77 ADRB2 (0.65) PLA2G1BATG4BALDH1A1TSHRMAPT
Isobutamben SCHEMBL4756252 0.76 ADRB2 (0.63) PLA2G1BATG4BALDH1A1TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9716235-B2 9,10-bis[2-(p-substituted phenyl)pyrimidin-4-yl] anthracene compounds, methods of preparing the same, organic electroluminescent devices and organic electroluminescent display apparatus BOE TECHNOLOGY GROUP CO., LTD. (CN) 2017-07-25 — — US disclosed
US-20150214487-A1 9,10-Bis[2-(p-substituted phenyl)pyrimidin-4-yl] Anthracene Compounds, Methods of Preparing the Same, Organic Electroluminescent Devices and Organic Electroluminescent Display Apparatus BOE TECHNOLOGY GROUP CO., LTD. (CN) 2015-07-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150214487-A1 9,10-Bis[2-(p-substituted phenyl)pyrimidin-4-yl] Anthracene Compounds, Methods of Preparing the Same, Organic Electroluminescent Devices and Organic Electroluminescent Display Apparatus P2RY10, P2RY4, APRT PLA2G1B 1727/4885ATG4B 772/4885ALDH1A1 283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback